Adding free to total prostate-specific antigen levels in trials of prostate cancer screening (Q36621170)

15 August 2017

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening (English)

1 reference

prostate cancer screening

15 August 2017

1 reference

Wald NJ

1

1 reference

15 August 2017

Watt HC

2

1 reference

15 August 2017

George L

3

1 reference

15 August 2017

Knekt P

4

1 reference

15 August 2017

Helzlsouer KJ

5

1 reference

15 August 2017

Tuomilehto J

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

82

1 reference

15 August 2017

3

1 reference

15 August 2017

731-736

1 reference

The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Serum vitamin E and subsequent risk of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Maternal serum screening for Down's syndrome in early pregnancy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Prostate-specific antigen levels and subsequent prostate cancer: potential for screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Prostate-specific antigen as a screening test for prostate cancer. The United States experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Model-based screening by risk with application to Down's syndrome

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project)

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363306

Serum vitamin E, serum selenium and the risk of gastrointestinal cancer

28 June 2018

1 reference

12 December 2020

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer

1 reference

12 December 2020

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

12 December 2020

Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group

1 reference

12 December 2020

Predictive properties of serum-prostate-specific antigen testing in a community-based setting

1 reference

12 December 2020

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples

1 reference

12 December 2020

Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.1999.0988

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

10682690

1 reference